Merck (NYSE: MRK) announced that it has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE